Home › Department of Health and Human Services › Contract HHSO100201700020C
REGENERON PHARMACEUTICALS INC
Federal contract HHSO100201700020C with Department of Health and Human Services, currently held by REGENERON PHARMACEUTICALS INC.
Expires 2027-09-24 · in 13 months
- Incumbent
- REGENERON PHARMACEUTICALS INC
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Industry (NAICS)
- 541711 - Research and Development in Biotechnology
- Ceiling value
- $279,610,568
- Period of performance
- 2017-09-21 to 2027-09-24
- Award ID
- HHSO100201700020C
Contract description
IGF::OT::IGF - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
Recompete context. This contract's current period of performance ends on
2027-09-24 (in 13 months). When a period of performance ends, the
agency typically either recompetes the work, extends the incumbent, or exercises a remaining option.
An end date is the earliest reliable public signal that a follow-on may be coming, which is why capture
teams track it. It is not a guarantee of a recompete. All figures are drawn from
USAspending.gov (U.S. Treasury) and are public domain.
Other Department of Health and Human Services contracts on the cliff
| Incumbent | Ceiling value | Ends | Expiry |
|---|---|---|---|
| NOVITAS SOLUTIONS, INC. | $921,080,482 | 2026-08-31 | expiring now |
| VERIZON BUSINESS NETWORK SERVICES LLC | $406,353,536 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $371,787,375 | 2026-08-30 | expiring now |
| LEIDOS, INC. | $152,046,866 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $87,806,507 | 2026-08-30 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $80,917,684 | 2026-08-31 | expiring now |